- Home
- GBIO vs EPOW Comparison
GBIO vs EPOW Comparison
Compare GBIO & EPOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- EPOW
- Stock Information
- Founded
- GBIO 2016
- EPOW 2014
- Country
- GBIO United States
- EPOW China
- Employees
- GBIO N/A
- EPOW N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- EPOW Business Services
- Sector
- GBIO Health Care
- EPOW Consumer Discretionary
- Exchange
- GBIO Nasdaq
- EPOW Nasdaq
- Market Cap
- GBIO 29.5M
- EPOW 24.8M
- IPO Year
- GBIO 2020
- EPOW 2021
- Fundamental
- Price
- GBIO $4.51
- EPOW $0.90
- Analyst Decision
- GBIO Strong Buy
- EPOW
- Analyst Count
- GBIO 4
- EPOW 0
- Target Price
- GBIO $73.33
- EPOW N/A
- AVG Volume (30 Days)
- GBIO 206.6K
- EPOW 16.4K
- Earning Date
- GBIO 08-06-2025
- EPOW 08-05-2025
- Dividend Yield
- GBIO N/A
- EPOW N/A
- EPS Growth
- GBIO N/A
- EPOW N/A
- EPS
- GBIO N/A
- EPOW N/A
- Revenue
- GBIO $24,556,000.00
- EPOW $64,997,741.00
- Revenue This Year
- GBIO N/A
- EPOW N/A
- Revenue Next Year
- GBIO N/A
- EPOW N/A
- P/E Ratio
- GBIO N/A
- EPOW N/A
- Revenue Growth
- GBIO 146.47
- EPOW 44.28
- 52 Week Low
- GBIO $3.00
- EPOW $0.55
- 52 Week High
- GBIO $34.35
- EPOW $1.36
- Technical
- Relative Strength Index (RSI)
- GBIO 54.72
- EPOW 46.09
- Support Level
- GBIO $4.05
- EPOW $0.87
- Resistance Level
- GBIO $5.10
- EPOW $0.95
- Average True Range (ATR)
- GBIO 0.63
- EPOW 0.04
- MACD
- GBIO 0.02
- EPOW -0.00
- Stochastic Oscillator
- GBIO 35.65
- EPOW 19.54
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is in the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.